Indaptus Therapeutics Initiates Unrestricted Enrollment of Patients on Decoy20 Weekly Dosing Based on Encouraging Safety Data
ソース:
Nasdaq GlobeNewswire
/
15 10 2024 08:00:00 America/New_York
N/A
シェアする